HRT pros and cons after 50 depend on which track you are on: menopausal hormone therapy for women, which is best at hot flashes and bone loss, and testosterone therapy for men, which helps men with diagnosed low testosterone and is not a treatment for normal aging.
Key Takeaways
- Systemic estrogen is “the most effective treatment for hot flashes and night sweats” (Mayo Clinic).
- Menopausal HRT’s benefits may outweigh its risks when it starts before age 60 or within 10 years of menopause (Mayo Clinic).
- The listed risks are heart disease, stroke, blood clots, breast cancer and gallbladder disease, and they vary with age, dose, type and history.
- Testosterone therapy is for diagnosed hypogonadism. Mayo Clinic says treating normal aging with it is “not advisable.”
- In the 5,246-man TRAVERSE trial, major cardiac events were 7.0% on testosterone and 7.3% on placebo (TRAVERSE trial).
- Both tracks start with a diagnosis, a doctor and a review date, not a prescription from a clinic ad.
Two people, both past 50, both tired of feeling like a stranger in their own body. One is thinking about estrogen. The other is thinking about testosterone.
They’re asking the same question, and the answers barely overlap. That’s why I’ve split this guide into two tracks. Read yours, then skim the other. You may be the one who ends up having this conversation with a partner.
What is HRT after 50?
“HRT” usually means menopausal hormone therapy for women. For men, the equivalent conversation is about testosterone therapy. They are different drugs for different problems, and the evidence behind them is different. If you’re still working out which stage you’re in, start with perimenopause vs menopause, and see menopause symptoms at 50 for what to expect around age 50.
| Menopausal hormone therapy | Testosterone therapy | |
|---|---|---|
| Who it is for | Women with moderate to severe symptoms | Men with diagnosed hypogonadism |
| Best-supported benefit | Hot flashes, night sweats, bone loss | Reversing hypogonadism; some sexual function gain |
| Main risks listed | Clots, stroke, breast cancer, heart disease | Sleep apnea, prostate, clots, heart (more research needed) |
| Source | Mayo Clinic | Mayo Clinic |
Confidence level: high. The table summarizes Mayo Clinic and Mayo Clinic. Neither page is a substitute for your own doctor, who knows your history.
What are the pros of menopausal HRT?
The case for it is strongest on symptoms and bones. Mayo Clinic describes systemic estrogen as “the most effective treatment for hot flashes and night sweats,” says therapy has been shown to help prevent bone loss and reduce broken bones after menopause, and says vaginal estrogen can ease dryness, itching and painful intercourse and may help some bladder symptoms.
It suits, per the same page, healthy women with moderate to severe hot flashes, vaginal or bladder symptoms, a need to prevent bone loss when other treatments fail, or early menopause. If you’re not sure whether your symptoms point that way, start with menopause insomnia and waking up at 3am, because broken sleep is often the first thing that sends people to a doctor. To track what you’re noticing before you go, use my perimenopause symptoms checklist.
What are the cons and risks of menopausal HRT?
Mayo Clinic lists a possible increased risk of heart disease, stroke, blood clots, breast cancer and gallbladder disease, plus endometrial cancer. Women who still have a uterus usually take a progestogen too, because estrogen alone can thicken the uterine lining. The page says risk depends on age, the type and dose of hormone, and personal health history, and that your history of cancer, heart disease, stroke, blood clots, liver disease and osteoporosis should be discussed with a clinician.
The regulatory picture has shifted. Patient Care’s report on the FDA change says the FDA approved labeling changes for six menopausal hormone therapy products that remove risk statements about cardiovascular disease, breast cancer and probable dementia from the boxed warning. It describes the first group of products to get updated labeling, with more expected. The report doesn’t say which boxed-warning statements remain, so I can’t tell you what stays on the label.
Confidence level: medium. I couldn’t open the FDA’s own announcement, so the label-change details come from a trade-press report. Read the current label and patient information for the specific product you’re offered.
Does the timing of HRT matter?
Yes, and it’s the most useful single fact in this debate. Mayo Clinic says the benefits may outweigh the risks when treatment starts “before age 60 or within 10 years of menopause.” Starting at 60 or older, or more than 10 years after menopause, is linked to a higher risk of serious complications.
The FDA made a similar point, per Patient Care’s report on the FDA change: randomized studies show women who start hormone therapy within 10 years of menopause onset, generally before age 60, see reductions in all-cause mortality and fractures.
Who is testosterone therapy for?
Men with a diagnosis, not men with a birthday. Mayo Clinic says testosterone therapy can help treat hypogonadism, where the testicles or pituitary gland don’t produce normal testosterone levels. It also says “there’s little evidence to support the use of testosterone in otherwise healthy men,” and that treating normal aging with it is “not advisable.”
The American College of Physicians guideline (January 2020) goes further. It says to discuss starting testosterone only with men who have sexual dysfunction and want better sexual and erectile function, to reassess within 12 months, and to stop if sexual function doesn’t improve. It says not to start it for energy, mood, physical function or cognition, because the evidence shows it isn’t effective for those.
Diagnosis comes first. Mayo Clinic says your doctor will likely measure your testosterone at least twice. Reading a result in context takes some care, which is why I wrote testosterone levels by age. If you want a baseline before you book, see at-home blood test kits.
What are the pros and cons of testosterone therapy?
On the plus side, Mayo Clinic says it can reverse the effects of hypogonadism and might improve sexual function somewhat in some men. On the minus side, it lists worsened sleep apnea, noncancerous prostate enlargement and possible stimulation of existing prostate cancer, excess red blood cell production that raises clot risk, acne, breast enlargement and reduced sperm production.
The heart question got a big test. The TRAVERSE trial enrolled 5,246 men aged 45 to 80 who had, or were at high risk of, cardiovascular disease and reported symptoms of hypogonadism, and followed them for a mean of 22 months. The composite of cardiovascular death, nonfatal heart attack or nonfatal stroke occurred in 182 men (7.0%) on testosterone and 190 (7.3%) on placebo. Atrial fibrillation, acute kidney injury and venous clots were higher on testosterone.
Confidence level: medium. TRAVERSE tested men with symptoms of hypogonadism and high cardiovascular risk, for under two years on average. It doesn’t tell you what happens over decades, or in men who don’t have low testosterone.
What can you try before or alongside hormones?
Cleveland Clinic lists lifestyle changes (diet, trigger avoidance, exercise, support groups, CBT, hypnotherapy) and nonhormonal prescriptions for menopause symptoms, including certain antidepressants, fezolinetant, elinzanetant and gabapentin. For men with age-related decline, Mayo Clinic suggests lifestyle approaches such as weight loss and resistance exercise.
That lines up with what I keep landing on: the basics beat biohacks. Daily movement (walking 2 miles a day, how many steps a day), a steady sleep routine you can check with a tracker (best sleep trackers), and less alcohol in the evening (alcohol and sleep after 50). Strength and balance work protects the bones either track is worried about: balance exercises for seniors.
Be wary of supplements sold as “natural hormone support.” I looked at what is worth buying in best vitamins after 50, and at the risks of stacking pills in supplement interactions after 50. None of the medical pages I read list a supplement as a replacement for hormone treatment.
What should you ask your doctor about hormone therapy?
- What exactly is the diagnosis, and what test confirms it?
- How old am I, and how long since menopause (or since my symptoms started)?
- Which form and dose, and why that one?
- What in my history changes the risk: cancer, clots, heart disease, stroke, liver disease?
- When do we review whether it is still worth it?
The last question matters. Mayo Clinic says to use the lowest estrogen dose that controls symptoms, only for as long as you need it, with regular follow-up. The American College of Physicians says to reassess testosterone within 12 months and stop if it isn’t working. Both tracks are trials with a review date. For the wider picture of staying well past 50, my Health After 50 hub has the rest.
Two people, two prescriptions, one rule: the drug is not the plan. The plan is the conversation, and the review date at the end of it.
HRT pros and cons: your questions answered
What are the main pros and cons of HRT?
For menopausal hormone therapy, Mayo Clinic calls systemic estrogen “the most effective treatment for hot flashes and night sweats,” and says it helps prevent bone loss. The listed risks are heart disease, stroke, blood clots, breast cancer, gallbladder disease and, without a progestogen, endometrial cancer. Risk depends on age, hormone type, dose and personal history.
Is HRT safe after 50?
It depends on your age, your history and when you start. Mayo Clinic says benefits may outweigh risks when treatment starts before age 60 or within 10 years of menopause, and that starting later is linked to a higher risk of serious complications.
Did the FDA remove the HRT warning?
Partly. Patient Care’s report on the FDA change says the FDA approved labeling changes for six menopausal hormone therapy products that remove risk statements about cardiovascular disease, breast cancer and probable dementia from the boxed warning. The report doesn’t say which boxed-warning statements remain, so check the label for your own product.
What are the pros and cons of testosterone therapy for men?
Mayo Clinic says testosterone therapy can help reverse the effects of hypogonadism and might improve sexual function somewhat in some men. Risks include worsened sleep apnea, prostate enlargement, more red blood cells and clot risk, and possibly heart disease risk, which it says needs more research.
Does testosterone therapy raise heart attack risk?
The TRAVERSE trial followed 5,246 men aged 45 to 80 with, or at high risk of, cardiovascular disease and symptoms of hypogonadism, for a mean of 22 months. Major cardiac events occurred in 7.0% on testosterone and 7.3% on placebo. Atrial fibrillation, acute kidney injury and venous blood clots were more common on testosterone.
Should every man over 50 take testosterone?
No. Mayo Clinic says treating normal aging with testosterone therapy is not advisable. The American College of Physicians says to start it only for men with sexual dysfunction who want better sexual and erectile function, and not for energy, mood, physical function or cognition.
How do I know if my testosterone is low?
Mayo Clinic says your doctor will likely measure your testosterone levels at least twice before recommending therapy. I explain how levels shift with age in testosterone levels by age, and compare home options in at-home blood test kits.
Are there non-hormone options for menopause symptoms?
Yes. Cleveland Clinic lists lifestyle changes (diet, trigger avoidance, exercise, support groups, CBT, hypnotherapy) and prescription medications such as certain antidepressants, fezolinetant, elinzanetant, gabapentin and oxybutynin, plus vaginal products.
Methodology. Menopausal hormone therapy facts come from Mayo Clinic (updated April 18, 2025), Cleveland Clinic (reviewed June 24, 2024) and Patient Care’s report on the FDA change. Testosterone facts come from Mayo Clinic (January 19, 2024), the American College of Physicians guideline press release (January 7, 2020) and the Cleveland Clinic newsroom summary of the TRAVERSE trial (June 16, 2023). I read each page directly. The NHS and Cleveland Clinic hormone therapy pages and the FDA’s own announcement failed to load, so I didn’t use them.
I left out forum posts, social media, clinic marketing pages and supplement-company content, because none can support a claim about hormones. Where the evidence is thin or comes second-hand, I’ve said so. This isn’t medical advice. Take your own situation to your own doctor.
